Financials Ortoma AB

Equities

ORT B

SE0005676103

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm 08:07:20 2024-05-31 EDT 5-day change 1st Jan Change
7.82 SEK +0.26% Intraday chart for Ortoma AB -2.98% -25.52%

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 146.7 289.3 289.3 -
Enterprise Value (EV) 1 146.7 320.7 237 262.3
P/E ratio -9.37 x -9.55 x 15.6 x -9.75 x
Yield - - - -
Capitalization / Revenue - 9.75 x 3.28 x 4.9 x
EV / Revenue - 8.41 x 2.69 x 4.44 x
EV / EBITDA - -20.3 x 7.16 x -16.6 x
EV / FCF - -30.3 x 237 x -10.1 x
FCF Yield - -3.3% 0.42% -9.91%
Price to Book - - - -
Nbr of stocks (in thousands) 19,821 37,084 37,084 -
Reference price 2 7.400 7.800 7.800 7.800
Announcement Date 23-01-20 24-02-20 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 38.14 88.1 59
EBITDA 1 - -15.83 33.1 -15.8
EBIT 1 - -21.98 19.1 -29.8
Operating Margin - -57.64% 21.68% -50.51%
Earnings before Tax (EBT) 1 - -21.87 18 -31
Net income 1 -15.75 -21.87 18 -31
Net margin - -57.35% 20.43% -52.54%
EPS 2 -0.7900 -1.100 0.5000 -0.8000
Free Cash Flow 1 - -10.59 1 -26
FCF margin - -27.76% 1.14% -44.07%
FCF Conversion (EBITDA) - - 3.02% -
FCF Conversion (Net income) - - 5.56% -
Dividend per Share - - - -
Announcement Date 23-01-20 24-02-20 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3 2023 Q4
Net sales 1 25.09 10.3 15.6
EBITDA 1 13.14 -0.627 -24.53
EBIT 1 13.12 -1.9 -29.37
Operating Margin 52.27% -18.44% -188.3%
Earnings before Tax (EBT) - - -
Net income - - -
Net margin - - -
EPS - - -
Dividend per Share - - -
Announcement Date 23-08-22 23-10-26 24-02-20
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt 1 - - - -
Net Cash position 1 - 51.2 52.3 27
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 - -10.6 1 -26
ROE (net income / shareholders' equity) - -15.2% 10% -18%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share - - - -
Cash Flow per Share - - - -
Capex 1 - - - 1
Capex / Sales - - - 1.69%
Announcement Date 23-01-20 24-02-20 - -
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise